Oct
2
2 Oct 12:00 PM to 2 Oct 01:00 PM
In this webinar, Dr. Blakney will discuss the development of next-generation saRNA platforms designed to generate prolonged therapeutic effects while requiring substantially lower doses than conventional RNA approaches. She will explore how engineering RNA constructs and optimizing nanoparticle delivery systems can enhance RNA expression, improve therapeutic performance, and enable new applications across infectious diseases, cancer, and genetic disorders.

Search
  • https://mrna.creative-biolabs.com/engineering-sarna-delivery-systems-for-therapeutics.htm
    Key points to be discussed during the session:

    How self-amplifying RNA (saRNA) technologies can achieve potent and durable therapeutic effects at significantly lower doses
    How molecular engineering strategies can be used to optimize saRNA design and performance
    How nanoparticle delivery systems can be engineered to improve the efficiency, safety, and effectiveness of saRNA therapeutics
    The potential of next-generation saRNA platforms for vaccines and therapies targeting infectious diseases, cancer, and genetic disorders
    https://mrna.creative-biolabs.com/engineering-sarna-delivery-systems-for-therapeutics.htm Key points to be discussed during the session: How self-amplifying RNA (saRNA) technologies can achieve potent and durable therapeutic effects at significantly lower doses How molecular engineering strategies can be used to optimize saRNA design and performance How nanoparticle delivery systems can be engineered to improve the efficiency, safety, and effectiveness of saRNA therapeutics The potential of next-generation saRNA platforms for vaccines and therapies targeting infectious diseases, cancer, and genetic disorders
    0 Comments 0 Shares 15 Views 0 Reviews
More Stories